178 related articles for article (PubMed ID: 6423169)
21. Frequency of G-985 mutation in medium chain acyl-coenzyme A dehydrogenase (MCAD) deficiency in sudden infant death syndrome (SIDS).
Miller M; Brooks J; Forbes N; Insel R
Prog Clin Biol Res; 1992; 375():495-8. PubMed ID: 1438393
[No Abstract] [Full Text] [Related]
22. Investigation of inborn errors of metabolism in unexpected infant deaths.
Emery JL; Howat AJ; Variend S; Vawter GF
Lancet; 1988 Jul; 2(8601):29-31. PubMed ID: 2898629
[No Abstract] [Full Text] [Related]
23. Reye syndrome versus defects in oxidation of fatty acids.
Wilson BE; Anderson LW
J Pediatr; 1986 Jan; 108(1):159. PubMed ID: 3944684
[No Abstract] [Full Text] [Related]
24. Defects of metabolism of fatty acids in the sudden infant death syndrome.
Howat AJ; Bennett MJ; Variend S; Shaw L; Engel PC
Br Med J (Clin Res Ed); 1985 Jun; 290(6484):1771-3. PubMed ID: 3924247
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of medium-chain acyl-coenzyme A dehydrogenase deficiency in the sudden infant death syndrome.
Arens R; Gozal D; Jain K; Muscati S; Heuser ET; Williams JC; Keens TG; Ward SL
J Pediatr; 1993 May; 122(5 Pt 1):715-8. PubMed ID: 8496748
[TBL] [Abstract][Full Text] [Related]
26. Multiple acyl-coenzyme A dehydrogenase deficiency: diagnosis by acyl-carnitine analysis of a 12-year-old newborn screening card.
Poplawski NK; Ranieri E; Harrison JR; Fletcher JM
J Pediatr; 1999 Jun; 134(6):764-6. PubMed ID: 10356148
[TBL] [Abstract][Full Text] [Related]
27. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.
Boles RG; Buck EA; Blitzer MG; Platt MS; Cowan TM; Martin SK; Yoon H; Madsen JA; Reyes-Mugica M; Rinaldo P
J Pediatr; 1998 Jun; 132(6):924-33. PubMed ID: 9627580
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic potential of stored dried blood spots for inborn errors of metabolism: a metabolic autopsy of medium-chain acyl-CoA dehydrogenase deficiency.
Kaku N; Ihara K; Hirata Y; Yamada K; Lee S; Kanemasa H; Motomura Y; Baba H; Tanaka T; Sakai Y; Maehara Y; Ohga S
J Clin Pathol; 2018 Oct; 71(10):885-889. PubMed ID: 29720407
[TBL] [Abstract][Full Text] [Related]
29. Determination of total fatty acids in plasma: cis-5-tetradecenoic acid (C14:1 omega-9) in the diagnosis of long-chain fatty acid oxidation defects.
Divry P; Vianey-Saban C; Mathieu M
J Inherit Metab Dis; 1999 May; 22(3):286-8. PubMed ID: 10384388
[No Abstract] [Full Text] [Related]
30. MCAD deficiency. Acylcarnitines (AC) by tandem mass spectrometry (MS-MS) are useful to monitor dietary treatment.
Abdenur JE; Chamoles NA; Specola N; Schenone AB; Jorge L; Guinle A; Bernard CI; Levandowskiy V; Lavorgna S
Adv Exp Med Biol; 1999; 466():353-63. PubMed ID: 10709663
[No Abstract] [Full Text] [Related]
31. [Acute encephalopathy and recurrent hepatic steatosis with normal long and medium chain fatty acyl-CoA-dehydrogenase activity].
Marandian MH; Soltanabadi A; Rakchan M; Kouchanfar A; Fallah A
Arch Fr Pediatr; 1987 May; 44(5):369-71. PubMed ID: 3619569
[TBL] [Abstract][Full Text] [Related]
32. The metabolic crisis: a diagnostic challenge [editoria; comment].
Bove KE
J Pediatr; 1997 Aug; 131(2):181-2. PubMed ID: 9290601
[No Abstract] [Full Text] [Related]
33. [Medium-chain acyl-CoA dehydrogenase defect. Acute cerebral episodes and nonketotic hypoglycemia in children].
von Mühlendahl KE; Lehnert W; Mönch E
Dtsch Med Wochenschr; 1990 Aug; 115(33):1235-8. PubMed ID: 2387217
[TBL] [Abstract][Full Text] [Related]
34. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes.
Roe CR; Millington DS; Maltby DA; Kinnebrew P
J Pediatr; 1986 Jan; 108(1):13-8. PubMed ID: 3944676
[TBL] [Abstract][Full Text] [Related]
35. Fatty acid oxidation defects.
von Döbeln U
Acta Paediatr Suppl; 1993 Jun; 82 Suppl 389():88-90. PubMed ID: 8374203
[No Abstract] [Full Text] [Related]
36. Sudden infant death and multiple acyl-CoA dehydrogenation disorders.
Parini R; Vegni C; Martini J; Romeo A; Garavaglia B
Eur J Pediatr; 1995 May; 154(5):421-2. PubMed ID: 7641783
[No Abstract] [Full Text] [Related]
37. Octanoate and palmitate beta-oxidation in human leukocytes: implications for the rapid diagnosis of fatty acid beta-oxidation disorders.
Wanders RJ; Ijlst L; van Elk E; de Klerk JB; Przyrembel H
J Inherit Metab Dis; 1991; 14(3):317-20. PubMed ID: 1770782
[No Abstract] [Full Text] [Related]
38. Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation.
Harpey JP; Charpentier C; Paturneau-Jouas M
Biol Neonate; 1990; 58 Suppl 1():70-80. PubMed ID: 2265221
[TBL] [Abstract][Full Text] [Related]
39. Comment on "Whole blood levels of dodecanoic acid, a routinely detectable forensic marker for a genetic disease often misdiagnosed as sudden infant death syndrome (SIDS): MCAD deficiency".
Ross KF; Guileyardo JM; Bennett MJ; Barnard JJ
Am J Forensic Med Pathol; 1996 Dec; 17(4):349-50. PubMed ID: 8947364
[No Abstract] [Full Text] [Related]
40. Post-mortem recognition of inherited metabolic disorders from specific acylcarnitines in tissue in cases of sudden infant death.
Roe CR; Millington DS; Maltby DA; Wellman RB
Lancet; 1987 Feb; 1(8531):512. PubMed ID: 2881073
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
